San Diego: Changemaker Chats with Merrilyn Datta

Merrilyn Datta, Ph.D
Head of Business Operations, Illumina

Join us on Monday, December 4 for our next Changemaker Chat with Merrilyn Datta, Ph.D., Head of Business for Illumina.

A prime example of the importance of STEM education for young girls, Merrilyn Datta fell in love with science when she was 7 years old and first saw a cell under a microscope. From there she not only fell in love with molecular biology but gained a passion for how science and technology can improve society. Merrilyn is a life sciences and technology executive with 20+ years experience the commercialization of technology. She has led businesses and crafted strategies across multiple markets from genomics to gene delivery to digital pathology.

In this conversation, we will be exploring the theme of ‘community’, and discussing ways female leaders can forge exciting careers in industries where women are traditionally under-represented. 

When: Monday, December 4, 2017
Arrival: 6:00 p.m.- 8:00 p.m.
Tickets: Interested in joining this Changemaker Chat? Click here to request an invite.

About Merrylin
Merrilyn Datta fell in love with science when she was 7 years old and first saw a cell under a microscope. From there she not only fell in love with molecular biology but gained a passion for how science and technology can improve society. Merrilyn is a life sciences and technology executive with 20+ years experience the commercialization of technology. She has led businesses and crafted strategies across multiple markets from genomics to gene delivery to digital pathology. Merrilyn began her career by joining Invitrogen in 1997 where she had multiple positions in marketing and strategy before moving into mergers and acquistions. Next, Merrilyn moved into the digital space, taking over responsibility for delivering over $1B in eCommerce revenue and creating the first digital ecosystem for scientists. In 2013, Merrilyn joined Definiens as Chief Commercial Officer, with a focus on driving all aspects of commercialization of their cognitive compute platform for digital pathology. Merrilyn spent 3 years as Chief Commercial Officer and was an integral part of the sale of the company to AstraZeneca in 2014. Merrilyn is currently Head of Business Operations for Illumina. In this capacity, Merrilyn ensures Illumina is successfully executing on the key growth vectors for sequencing in life sciences and healthcare. Merrilyn has a passion for innovation and serves as an mentor in The Start-Up Leadership Program and additionally advises a small biotech companies. She has a Ph.D. in Biochemistry and an M.S. in Molecular Genetics from Harvard and an M.B.A. from University of California, Irvine. In her spare time, Merrilyn likes to read, try out new gadgets, or go to the beach with her family.